Oppenheimer Lowers EPS, Revenue Estimates for PacBio Following Layoffs | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Oppenheimer today cut Pacific Biosciences' 2011 EPS estimate and 2012 to 2014 revenue estimates following the company's announcement earlier this week that it was slicing its workforce by 130 positions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.